Dutasteride soft capsule preparation and preparation process thereof

A technology of soft capsule preparation and dutasteride, which is applied in the direction of capsule delivery, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., and can solve the problem of not being able to significantly improve the dissolution of soft capsules containing dutasteride Problems such as degree, influence on the stability and bioavailability of preparations, migration of active pharmaceutical compounds, etc., to achieve the effects of good product appearance quality, improved cumulative dissolution rate, and good stability

Active Publication Date: 2016-03-16
成都华宇制药有限公司
View PDF6 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After it is prepared into a soft capsule preparation, due to the addition of propylene glycol in the soft capsule content, it is easy to cause the active drug compound to migrate into the rubber during drying and storage, thereby affecting the stability and bioavailability of the preparation
[0005] Since the addition of propylene glycol will have a certain impact on the migration o

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dutasteride soft capsule preparation and preparation process thereof
  • Dutasteride soft capsule preparation and preparation process thereof
  • Dutasteride soft capsule preparation and preparation process thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Prescription of contents of dutasteride soft capsule preparation:

[0058] Dutasteride raw material 0.5g; caprylic capric acid macrogol glyceride 220g;

[0059] Polyglycerol oleate 45g; medium chain triglyceride 75g;

[0060] 0.035 g of 2,6-di-tert-butyl-p-cresol.

[0061] Softgel prescription:

[0062] Gelatin 160mg; Glycerin 85mg;

[0063] Yellow iron oxide 0.28mg; titanium dioxide 2mg.

[0064] Preparation:

[0065] (1) Preparation of contents: Take the prescription amount of caprylic capric acid macrogolglyceride, polyglycerol oleate and medium chain triglyceride and stir evenly, add the prescribed amount of dutasteride raw material after heating up to 40°C drug and 2,6-di-tert-butyl-p-cresol, continue to stir for 1h until uniform, and then cool down to room temperature to obtain the content;

[0066] (2) Preparation of soft capsules: Take the prescribed amount of glycerin, add water, put it in a plastic tank, stir and mix evenly, then add titanium dioxide and...

Embodiment 2

[0069] Prescription of contents of dutasteride soft capsule preparation:

[0070] Dutasteride raw material 0.5g; caprylic capric acid macrogol glyceride 225g;

[0071] Polyglycerol oleate 50g; medium chain triglyceride 72g;

[0072] 0.038g of 2,6-di-tert-butyl-p-cresol.

[0073] Softgel prescription:

[0074] Gelatin 165mg; Glycerin 83mg;

[0075] Yellow iron oxide 0.27mg; titanium dioxide 2.2mg.

[0076] Preparation:

[0077] (1) Preparation of contents: Take the prescription amount of caprylic capric acid macrogolglyceride, polyglycerol oleate and medium chain triglyceride and stir evenly, add the prescribed amount of dutasteride raw material after heating up to 40°C drug and 2,6-di-tert-butyl-p-cresol, continue to stir for 1h until uniform, and then cool down to room temperature to obtain the content;

[0078] (2) Preparation of soft capsules: Take the prescribed amount of glycerin, add water, put it in a plastic tank, stir and mix evenly, then add titanium dioxide and ...

Embodiment 3

[0081] Prescription of contents of dutasteride soft capsule preparation:

[0082] Dutasteride raw material 0.5g; caprylic capric acid macrogol glyceride 220g;

[0083] Polyglycerol oleate 45g; medium chain triglyceride 75g;

[0084] Softgel prescription:

[0085] Gelatin 160mg; Glycerin 85mg;

[0086] Yellow iron oxide 0.28mg; titanium dioxide 2mg.

[0087] Preparation:

[0088] (1) Preparation of contents: Take the prescription amount of caprylic capric acid macrogolglyceride, polyglycerol oleate and medium chain triglyceride and stir evenly, add the prescribed amount of dutasteride raw material after heating up to 40°C Continue to stir the medicine for 1 hour until it is uniform and then cool down to room temperature to obtain the content;

[0089] (2) Preparation of soft capsules: Take the prescribed amount of glycerin, add water, put it in a plastic tank, stir and mix evenly, then add titanium dioxide and yellow iron oxide passed through an 80-mesh sieve and mix evenl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a dutasteride soft capsule preparation, comprising a soft capsule and contents. A prescription for the contents comprises 0.5 g of a dutasteride raw material, 200 to 250 g of labrasol, 30 to 60 g of polyglycerol oleate, 50 to 100 g of medium-chain triglyceride and 0.02 to 0.05 g of 2,6-di-t-butyl p-cresol. The dutasteride soft capsule prepared in the invention is substantially improved in accumulated dissolution in 5 minutes of dissolving-out and enhanced in the dissolving-out efficiency of a main drug in a preceding time period and has good stability and good appearance quality.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a dutasteride soft capsule preparation and a preparation process thereof. Background technique [0002] Dutasteride is a 5α-reductase inhibitor. There are two subtypes of 5α-reductase, namely type I and type II. Type I isozyme acts on the reproductive system, and type II isozyme mainly acts on the skin and Hepatic testosterone conversion. Dutasteride is 60 times more effective at inhibiting type I 5α reductase than finasteride, and it also has a strong effect on type II. Dutasteride can inhibit the conversion of testosterone into dihydrotestosterone (DHT), thereby inhibiting the production of male DHT. production, thereby inhibiting the growth of the prostate in BPH patients. Clinically, it is mainly used for the treatment of enlarged prostate, male pattern alopecia, seborrheic alopecia, and hereditary alopecia. [0003] The dosage form of dutasteride on th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/48A61K31/58A61K47/10A61P13/08A61P17/14
CPCA61K9/4858A61K31/58
Inventor 罗朝斌万久磊
Owner 成都华宇制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap